Market Data 
Markets
Replies to post #256298 on Biotech Values
11/01/25 4:29 PM
Metsera…today issued the following statement in response to litigation filed against the Company by Pfizer: "Metsera disagrees with the allegations in Pfizer's complaint and will address them in the Delaware Court of Chancery."
In any event, a temporary injunction from the Chancery Court greatly increases PFE’s leverage.
11/02/25 2:35 PM
...the one-week-early FTC clearance for the PFE-MTSR merger (#msg-176890987) was not happenstance!
Novo’s shady strategy is to make an early payment for Metsera shares. That would effectively give Novo economic control of Metsera and undue influence on the company before the transaction even undergoes regulatory review. While a Danish company buying an American one doesn’t necessarily represent an obvious threat to national security, permitting Novo to acquire a promising U.S.-based biotech company could lead to American job losses and profits getting sent abroad.
11/03/25 12:00 PM
11/04/25 9:59 AM
AI
